Product Description: D-Cycloserine is an antibiotic which targets sequential bacterial cell wall peptidoglycan biosynthesis enzymes. D-Cycloserine is a partial NMDA agonist that can improve cognitive functions. D-Cycloserine can be used for multidrug-resistant tuberculosis research[1][2].
Applications: COVID-19-immunoregulation
Formula: C3H6N2O2
References: [1]Nitsche, M.A., et al., Consolidation of human motor cortical neuroplasticity by D-cycloserine. Neuropsychopharmacology, 2004. 29(8): p. 1573-8./[2]Levin, E.D., et al., D-cycloserine selectively decreases nicotine self-administration in rats with low baseline levels of response. Pharmacol Biochem Behav, 2011. 98(2): p. 210-4./[3]Sarah Batson, et al. Inhibition of D-Ala:D-Ala ligase through a phosphorylated form of the antibiotic D-cycloserine. Nat Commun. 2017 Dec 5;8(1):1939.
CAS Number: 68-41-7
Molecular Weight: 102.09
Compound Purity: 99.97
Research Area: Infection; Neurological Disease; Cancer
Solubility: DMSO : 1 mg/mL (warming)/H2O : 25 mg/mL (ultrasonic)
Target: Antibiotic;Bacterial;iGluR